サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494349

欧州の流動性止血剤の2028年市場予測-地域別分析：材料、製品、用途、エンドユーザー別

Europe Flowable Hemostats Market Forecast to 2028 - Regional Analysis - by Material, Product, Application, and End User

出版日
ページ情報
英文 138 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
欧州の流動性止血剤の2028年市場予測-地域別分析：材料、製品、用途、エンドユーザー別
出版日: 2024年03月14日
発行: The Insight Partners
ページ情報: 英文 138 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の流動性止血剤市場は、2022年の2億1,554万米ドルから2028年には3億2,823万米ドルに成長すると予測されています。2022年から2028年までのCAGRは7.3％と推定されます。

病院・手術センター数の増加が欧州の流動性止血剤市場を活性化

病院や手術センターの数は、先進地域や新興地域で急速に増加しています。このような成長は、最近設立された手術センターや病院向けの手術機器（医療機器や止血剤製品を含む）の需要を加速させています。2020年10月、米国首相は40の病院設立のために約43億米ドルを投資する計画を発表し、2030年までに48の病院に将来資金を提供する計画も発表しました。さらに、ヘルスケア分野の成長は、流動性止血剤市場に有利な機会を提供しています。ヘルスケア産業は近年急速な変貌を遂げています。世界中の様々な国がヘルスケアにおける先進技術を支持しています。より良いヘルスケア施設の必要性に伴い、テクノロジー・イネーブルド・ケア（TEC）ソリューションが、特に新興国のヘルスケアシステムで参照されるようになっています。慢性疾患の増加、高齢化人口の増加、小児医療などの主な要因が、ヘルスケア産業の成長を後押ししています。技術的手技の増加に伴い、局所止血剤の有効性が臨床転帰の改善に役立つ可能性があります。したがって、理想的な局所止血剤は、確実かつ迅速な出血コントロールを提供するものです。このような病院や手術センターの数の著しい成長は、流動性止血剤の製品の高い採用を要求し、最終的に今後数年間の市場の成長に有利な成長機会を提供します。

欧州の流動性止血剤市場概要

欧州の流動性止血剤市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州にまたがります。この地域市場は、外科手術件数の増加、政府のイニシアチブの増加、ヘルスケア支出の増加、その他いくつかの要因によって、2022年から2028年にかけて7.3%の安定した成長率が見込まれています。ドイツには、世界中の患者を治療するための特別な医療施設と訓練を受けた医師がいます。その上、この国には最先端の医療訓練施設があり、医師は大規模な教育、研修、診療を受ける必要があります。ドイツ連邦統計局から得た調査によると、同国には2020年に約951,936人の病院スタッフと約1,903の病院があり、今後数年間で同国の手術件数が増加すると予想されています。外科手術件数の増加は、ドイツにおける止血剤市場の上昇を支える重要な要因です。例えば、ドイツ胸部心臓血管外科学会（GSTCVS）によると、2019年には全国で約161,817件の手術が登録され、そのうち92,809件が心臓手術でした。さらに、ドイツは最大の医療技術市場であり、国際的にも第3位にランクされています。約11,000の医療機器が国内で製造されており、医療機器の売上の3分の2は国内市場以外で生産されたものです。ドイツには、革新的な医療技術に特化したクラスターネットワークが30以上あります。ドイツ政府の国家ハイテク戦略2020は、省庁横断的な広範な事前戦略として策定されました。このため、病院数の増加や手術件数の増加などの要因が、予測期間中にこの市場を押し上げるとみられます。

欧州の流動性止血剤市場の収益と2028年までの予測（金額）

欧州の流動性止血剤市場のセグメンテーション

欧州の流動性止血剤市場は、材料、製品、用途、エンドユーザー、国に区分されます。

材料別では、欧州の流動性止血剤市場は牛ゼラチンと豚ゼラチンに二分されます。2022年の欧州の流動性止血剤市場では、牛ゼラチンセグメントが大きなシェアを占めています。

製品別では、欧州の流動性止血剤市場はコンビネーション止血剤、パッシブ止血剤、アクティブ止血剤に区分されます。2022年の欧州の流動性止血剤市場では、コンビネーション止血剤分野が最大シェアを占めています。

用途別では、欧州の流動性止血剤市場は一般外科、心臓外科、血管外科、整形外科、神経・脊椎外科、その他に分類されます。2022年の欧州の流動性止血剤市場では、一般外科分野が最大のシェアを占めています。

エンドユーザー別に見ると、欧州の流動性止血剤市場は病院・診療所、外来手術センター、その他に区分されます。2022年の欧州の流動性止血剤市場では、病院・診療所セグメントが最大シェアを占めています。

国別では、欧州の流動性止血剤市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に分類されます。2022年の欧州の流動性止血剤市場はドイツが独占。

Baxter International Inc、Ethicon（Johnson &Johnson）、Pfizer Inc、Teleflex Incorporated、3-D Matrix Medical Technology、Biom'up、Aegis Lifesciencesは、欧州の流動性止血剤市場で事業を展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 要点

第3章 調査手法

  • カバー範囲
  • 2次調査
  • 1次調査

第4章 欧州の流動性止血剤市場- 市場情勢

  • 概観
  • 欧州PEST分析
  • 欧州の専門家の見解

第5章 欧州の流動性止血剤市場-主要市場力学

  • 市場促進要因
    • 怪我や外科手術の増加
    • 老人人口の増加
  • 市場抑制要因
    • 熟練専門家の不足と不十分な償還政策
  • 市場機会
    • 病院数と手術センター数の増加
  • 今後の動向
    • 製品革新につながる研究開発（R&D）活動
  • 影響分析

第6章 流動性止血剤の欧州市場分析

  • 欧州の流動性止血剤市場収益と分析
    • 欧州の流動性止血剤市場の収益予測と分析

第7章 流動性止血剤の欧州市場分析-素材別

  • 欧州の流動性止血剤市場、材料別シェア、2021年および2028年（%）
  • 牛ゼラチン
  • 豚ゼラチン

第8章 欧州の流動性止血剤の市場分析-製品別

  • コンビネーション止血剤
    • コンビネーション止血剤欧州の流動性止血剤市場-2028年までの収益と予測
  • 受動的止血剤
    • パッシブ止血剤欧州の流動性止血剤の市場-2028年までの収益と予測
  • 活性型止血剤
    • 活性止血剤：欧州の流動性止血剤市場-2028年までの収益と予測

第9章 欧州の流動性止血剤市場-用途別

  • 一般外科
    • 一般外科欧州の流動性止血剤市場-2028年までの収益と予測
  • 心臓外科
    • 心臓外科の概要
    • 心臓外科欧州の流動性止血剤の市場：収益と2028年までの予測
  • 血管外科
    • 血管外科
    • 血管外科欧州の流動性止血剤の市場：収益と2028年までの予測
  • 整形外科
    • 整形外科の概要
    • 整形外科欧州の流動性止血剤市場：2028年に至る収益と予測
  • 神経・脊椎外科
    • 神経外科と脊椎外科欧州の流動性止血剤の市場：収益と2028年までの予測
  • その他
    • その他
    • その他欧州の流動性止血剤市場：2028年に至る収益と予測

第10章 欧州の流動性止血剤市場分析：エンドユーザー別

  • 病院および診療所
  • 外来手術センター
  • その他

第11章 欧州の流動性止血剤市場の収益と2028年までの予測：国別分析

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第12章 欧州の流動性止血剤市場-業界情勢

  • 有機的展開
  • 無機的展開

第13章 企業プロファイル

  • Baxter International Inc
  • Ethicon（Johnson & Johnson）
  • Pfizer Inc.
  • Teleflex Incorporated
  • 3-D Matrix Medical Technology
  • Biom'up
  • Aegis Lifesciences

第14章 付録

図表

List Of Tables

  • Table 1. Germany: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 2. Germany: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 3. Germany: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 4. Germany: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 5. UK: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 6. UK: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 7. UK: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 8. UK: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 9. France: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 10. France: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 11. France: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 12. France: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 13. Italy: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 14. Italy: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 15. Italy: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 16. Italy: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 17. Spain: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 18. Spain: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 19. Spain: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 20. Spain: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 21. Rest of Europe: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 22. Rest of Europe: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 23. Rest of Europe: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 24. Rest of Europe: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 25. Organic Developments in the Flowable Hemostats Market
  • Table 26. Inorganic Developments in the Flowable Hemostats Market
  • Table 27. Europe Glossary of Terms

List Of Figures

  • Figure 1. Europe Flowable Hemostats Market Segmentation
  • Figure 2. Europe Flowable Hemostats Market, By Country
  • Figure 3. Europe Flowable Hemostats Market Overview
  • Figure 4. Bovine Gelatin Holds Maximum Share in Europe Flowable Hemostats Market
  • Figure 5. Europe Flowable Hemostats Market, by Country (US$ Million)
  • Figure 6. Europe Flowable Hemostats Market, Market Attractiveness
  • Figure 7. Europe: PEST Analysis
  • Figure 8. Europe Experts Opinion
  • Figure 9. Impact Analysis
  • Figure 10. Europe Flowable Hemostats Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 11. Europe Flowable Hemostats market Share, by Material, 2021 and 2028 (%)
  • Figure 12. Bovine Gelatin: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Europe Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
  • Figure 15. Combination Hemostat: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Passive Hemostat: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Active Hemostat: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Europe Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
  • Figure 19. General Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Cardiac Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Vascular Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Orthopedic Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Neuro and Spine Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Europe Flowable Hemostats Gown Market Share, by End User, 2021 and 2028 (%)
  • Figure 26. Hospitals and Clinics: Europe Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Ambulatory Surgery Centers: Europe Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Others: Europe Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Europe: Flowable Hemostats Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 30. Europe: Flowable Hemostats Market, by Country, 2021 & 2028 (%)
  • Figure 31. Germany: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 32. France: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 33. Italy: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 34. Spain: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 35. Rest of Europe: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 36. Growth Strategies in the Flowable Hemostats Market (%)
目次
Product Code: BMIRE00029827

The Europe flowable hemostats market is expected to grow from US$ 215.54 million in 2022 to US$ 328.23 million by 2028. It is estimated to grow at a CAGR of 7.3% from 2022 to 2028.

Increasing Number of Hospitals and Surgical Centers Fuel Europe Flowable Hemostats Market

The number of hospitals and surgical centers is increasing rapidly in developed and emerging regions. Such growth accelerates demand for surgical equipment (including medical devices and hemostat products) for lately established surgical centers and hospitals. In October 2020, the Prime Minister of the UK announced plans to invest around US$ 4.3 billion for the setting of 40 hospitals and a scheme for future funding for 48 hospitals by 2030. Furthermore, the growth in the healthcare sector offers lucrative opportunities for the flowable hemostats market. The healthcare industry has been encountering a rapid transformation in recent years. Various countries across the globe have favored advanced technologies in healthcare. With the need for better healthcare facilities, Technology-Enabled Care (TEC) solutions are being referred to in the healthcare systems, especially in emerging economies. Some of the primary factors, such as rising incidences of chronic illnesses, an increase in the aging population, and pediatric care, are helping boost the growth of the healthcare industry. With rising technical procedures, the effectiveness of topical hemostats may help improve clinical outcomes. Thus, the ideal topical hemostats would offer authentic and prompt bleeding control. Such significant growth in the number of hospitals and surgical centers demands high adoption of flowable hemostat products, ultimately offering lucrative growth opportunities for the market's growth during the coming years.

Europe Flowable Hemostats Market Overview

The Europe market for flowable hemostats is spread across Germany, the UK, France, Italy, Spain, and the Rest of Europe. This regional market is expected to witness a steady growth rate of 7.3% from 2022 to 2028 due to the rise in the number of surgical procedures, increasing government initiatives, growing healthcare expenditure, and several other factors. Germany has some specific medical facilities and trained physicians to treat patients worldwide. Besides, the country has the most advanced medical training facilities, and doctors are required to undergo extensive education, residency, and practice. As per the study obtained from the German Federal Statistical Office, the country had nearly 951,936 hospital staff and approximately 1,903 hospitals in 2020, which is expected to increase the number of surgeries in the country over the coming years. The growing number of surgical procedures is a crucial factor behind the rise in the hemostats market in Germany. For instance, according to the German Society for Thoracic and Cardiovascular Surgery (GSTCVS), around 161,817 procedures were registered in 2019 across the country, out of which 92,809 were cardiac surgeries. Furthermore, Germany is the largest medical technology market and ranks third internationally. Approximately 11,000 medical devices are manufactured in the country, and two-thirds of its sales of medical devices were produced outside its domestic market. Germany is home to more than 30 dedicated cluster networks dedicated to innovative medical technology. The German Government's national high-tech strategy 2020 developed as a broad, interdepartmental advance strategy. Thus, factors, such as the growing number of hospitals and the rise in the number of surgeries, are likely to boost this market during the forecast period.

Europe Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)

Europe Flowable Hemostats Market Segmentation

The Europe flowable hemostats market is segmented into material, product, application, end user, and country.

Based on material, the Europe flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held a larger share of the Europe flowable hemostats market in 2022.

In terms of product, the Europe flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held the largest share of the Europe flowable hemostats market in 2022.

Based on application, the Europe flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held the largest share of the Europe flowable hemostats market in 2022.

Based on end user, the Europe flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held the largest share of the Europe flowable hemostats market in 2022.

By country, the Europe flowable hemostats market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, Biom'up, and Aegis Lifesciences are some of the leading companies operating in the Europe flowable hemostats market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Flowable Hemostats Market - By Material
    • 1.3.2 Europe Flowable Hemostats Market - By Product
    • 1.3.3 Europe Flowable Hemostats Market - By Application
    • 1.3.4 Europe Flowable Hemostats Market - By End User
    • 1.3.5 Europe Flowable Hemostats Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Flowable Hemostats Market - Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis
  • 4.3 Europe Experts Opinion

5. Europe Flowable Hemostats Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Number of Injuries and Surgical Procedures
    • 5.1.2 Rising Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Number of Hospitals and Surgical Centers
  • 5.4 Future Trends
    • 5.4.1 Research and Development (R&D) Activities Leading to Product Innovations
  • 5.5 Impact Analysis

6. Flowable Hemostats Market - Europe Analysis

  • 6.1 Europe Flowable Hemostats Market Revenue Forecast & Analysis
    • 6.1.1 Europe Flowable Hemostats Market Revenue Forecast & Analysis

7. Europe Flowable Hemostats Market Analysis - By Material

  • 7.1 Europe Flowable Hemostats Market Share, by Material, 2021 and 2028 (%
  • 7.2 Bovine Gelatin
    • 7.2.1 Overview
    • 7.2.2 Bovine Gelatin: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 7.3 Porcine Gelatin
    • 7.3.1 Overview
    • 7.3.2 Porcine Gelatin: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

8. Europe Flowable Hemostats Market- By Product

  • 8.1 Overview
  • 8.2 Combination Hemostat
    • 8.2.1 Overview
    • 8.2.2 Combination Hemostat: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.3 Passive Hemostat
    • 8.3.1 Overview
    • 8.3.2 Passive Hemostat: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Active Hemostat
    • 8.4.1 Overview
    • 8.4.2 Active Hemostat: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9. Europe Flowable Hemostats Market- By Application

  • 9.1 Overview
  • 9.2 General Surgery
    • 9.2.1 Overview
    • 9.2.2 General Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.3 Cardiac Surgery
    • 9.3.1 Overview
    • 9.3.2 Cardiac Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Vascular Surgery
    • 9.4.1 Overview
    • 9.4.2 Vascular Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Orthopedic Surgery
    • 9.5.1 Overview
    • 9.5.2 Orthopedic Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Neuro and Spine Surgery
    • 9.6.1 Overview
    • 9.6.2 Neuro and Spine Surgery: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: Europe Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

10. Europe Flowable Hemostats Market Analysis - By End User

  • 10.1 Overview
  • 10.2 Hospitals and Clinics
    • 10.2.1 Overview
    • 10.2.2 Hospitals and Clinics: Europe Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.3 Ambulatory Surgery Centers
    • 10.3.1 Overview
    • 10.3.2 Ambulatory Surgery Centers: Europe Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Europe Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

11. Europe Flowable Hemostats Market Revenue and Forecasts to 2028 - Country Analysis

  • 11.1 Europe Flowable Hemostats Market Revenue and Forecast to 2028
    • 11.1.1 Overview
      • 11.1.1.1 Germany: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.1.1 Germany: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.1.2 Germany: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.1.3 Germany: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.1.4 Germany: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.1.5 Germany: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.1.2 UK: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.2.1 UK: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.2.2 UK: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.2.3 UK: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.2.4 UK: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.2.5 UK: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.1.3 France: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.3.1 France: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.3.2 France: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.3.3 France: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.3.4 France: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.3.5 France: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.1.4 Italy: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.4.1 Italy: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.4.2 Italy: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.4.3 Italy: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.4.4 Italy: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.4.5 Italy: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.1.5 Spain: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.5.1 Spain: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.5.2 Spain: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.5.3 Spain: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.5.4 Spain: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.5.5 Spain: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.1.6 Rest of Europe: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.6.1 Rest of Europe: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.6.2 Rest of Europe: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.6.3 Rest of Europe: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.6.4 Rest of Europe: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.6.5 Rest of Europe: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

12. Europe Flowable Hemostats Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Organic Developments
    • 12.2.1 Overview
  • 12.3 Inorganic Developments
    • 12.3.1 Overview

13. Company Profiles

  • 13.1 Baxter International Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Ethicon (Johnson & Johnson)
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Pfizer Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Teleflex Incorporated
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 3-D Matrix Medical Technology
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Biom'up
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Aegis Lifesciences
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Europe Glossary of Terms